Skip to main content
Erschienen in: Skeletal Radiology 8/2022

14.01.2022 | Case Report

NTRK-rearranged spindle cell neoplasm of the lower extremity: radiologic-pathologic correlation

verfasst von: Cameron J. Overfield, Mark A. Edgar, Daniel E. Wessell, Benjamin K. Wilke, Hillary W. Garner

Erschienen in: Skeletal Radiology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Neurotrophic tyrosine receptor kinase (NTRK)–rearranged spindle cell neoplasm is a recently characterized soft tissue tumor and has been classified as provisional by the World Health Organization. Detection of the genetic rearrangement is important because these tumors are amenable to targeted tyrosine kinase inhibitor therapy, which can play a key role in patients with unresectable or advanced disease. Although the spectrum of histopathology associated with this entity is broad, one notable feature is the infiltrative growth pattern, which is most reminiscent of lipofibromatosis-like neural tumor. Description of their diverse histologic attributes has aided recognition, but so far little attention has been paid to correlating the gross appearance and imaging features of these lesions. In this report, we describe the clinical, imaging, histopathological, and genetic features of a soft tissue NTRK-rearranged spindle cell neoplasm. Inclusion of this more recently identified entity into the imaging differential of tumors with intratumoral relatively hypovascular nodules and infiltrative margins is important because testing for NTRK rearrangement is not routinely performed.
Literatur
1.
Zurück zum Zitat WHO Classification of Tumours Editorial Board.WHO classification of tumours soft tissue and bone tumours, 5th edition. Lyon: IARC Press; 2020. WHO Classification of Tumours Editorial Board.WHO classification of tumours soft tissue and bone tumours, 5th edition. Lyon: IARC Press; 2020.
2.
Zurück zum Zitat Antonescu CR. Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria. Genes Chromosom Cancer. 2020;59(8):437–44.CrossRef Antonescu CR. Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria. Genes Chromosom Cancer. 2020;59(8):437–44.CrossRef
3.
Zurück zum Zitat Suurmeijer AJH, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, et al. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Genes Chromosom Cancer. 2018;57(12):611–21.CrossRef Suurmeijer AJH, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, et al. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Genes Chromosom Cancer. 2018;57(12):611–21.CrossRef
7.
Zurück zum Zitat Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Huang HY, Fletcher CD, Antonescu CR. The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements. Genes Chromosomes Cancer. 2019 Nov;58(11):739–746. doi: https://doi.org/10.1002/gcc.22767. Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Huang HY, Fletcher CD, Antonescu CR. The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements. Genes Chromosomes Cancer. 2019 Nov;58(11):739–746. doi: https://​doi.​org/​10.​1002/​gcc.​22767.
8.
Zurück zum Zitat Yamazaki F, Nakatani F, Asano N, Wakai S, Sekimizu N, Mitani S, Kubo T, Kawai A, Ichikawa H, Yoshida A. Novel NTRK3 fusions in fibrosarcomas of adults. Am J Surg Pathol. 2019;43:523–30.CrossRef Yamazaki F, Nakatani F, Asano N, Wakai S, Sekimizu N, Mitani S, Kubo T, Kawai A, Ichikawa H, Yoshida A. Novel NTRK3 fusions in fibrosarcomas of adults. Am J Surg Pathol. 2019;43:523–30.CrossRef
12.
Zurück zum Zitat Vaishnavi A, Le AT, Doebele RC. TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2015;5:25–34.CrossRef Vaishnavi A, Le AT, Doebele RC. TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2015;5:25–34.CrossRef
13.
Zurück zum Zitat Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA. Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol. 2017;41:1547–51.CrossRef Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA. Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol. 2017;41:1547–51.CrossRef
14.
Zurück zum Zitat Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, Dubois SG, et al. Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors. Am J Surg Pathol. 2019;43(4):435–45.CrossRef Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, Dubois SG, et al. Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors. Am J Surg Pathol. 2019;43(4):435–45.CrossRef
16.
20.
Zurück zum Zitat Papathanassiou ZG, Alberghini M, Picci P, Staals E, Gambarotti M, Garaci FG, Vanel D. Solitary fibrous tumors of the soft tissues: imaging features with histopathologic correlations. Clin Sarcoma Res. 2013;3(1):1. https://doi.org/10.1186/2045-3329-3-1. Papathanassiou ZG, Alberghini M, Picci P, Staals E, Gambarotti M, Garaci FG, Vanel D. Solitary fibrous tumors of the soft tissues: imaging features with histopathologic correlations. Clin Sarcoma Res. 2013;3(1):1. https://​doi.​org/​10.​1186/​2045-3329-3-1.
Metadaten
Titel
NTRK-rearranged spindle cell neoplasm of the lower extremity: radiologic-pathologic correlation
verfasst von
Cameron J. Overfield
Mark A. Edgar
Daniel E. Wessell
Benjamin K. Wilke
Hillary W. Garner
Publikationsdatum
14.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 8/2022
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-022-03995-w

Weitere Artikel der Ausgabe 8/2022

Skeletal Radiology 8/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.